Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-02-28 Sale |
2024-02-29 4:16 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
329 | $155.3 | $51,094 | 5,887 (Direct) |
View |
2024-02-02 Sale |
2024-02-05 4:05 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
1,591 | $170.99 | $272,050 | 8,759 (Direct) |
View |
2023-04-06 Sale |
2023-04-10 4:29 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
3,500 | $210 | $735,000 | 0 (Direct) |
View |
2023-02-02 Sale |
2023-02-03 5:46 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
1,675 | $226.01 | $378,563 | 13,850 (Direct) |
View |
2021-07-21 Sale |
2021-07-23 4:37 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
116,075 | $0 | $0 | 0 (Direct) |
View |
2020-06-08 Sale |
2020-06-09 5:05 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
6,853 | $114.69 | $785,981 | 28,218 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-02 Option Award |
2025-01-06 1:49 pm |
N/A N/A |
AVANOS MEDICAL INC. | AVNS | Franchini Indrani Lall Director |
12,003 | $0 | 16,820 (Direct) |
View |
Ownership(A) |
2024-07-03 5:07 pm |
N/A N/A |
AVANOS MEDICAL INC. | AVNS | Franchini Indrani Lall Director |
0 | $0 | 4,817 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 4:16 pm |
N/A 2026-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
878 | $0 | 5,887 (Direct) |
View |
2024-02-01 Exercise |
2024-02-05 4:05 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
5,175 | $0 | 8,759 (Direct) |
View |
2023-02-27 Option Award |
2023-03-01 4:21 pm |
N/A 2026-02-27 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
8,081 | $0 | 8,081 (Direct) |
View |
2023-02-01 Exercise |
2023-02-03 5:46 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
5,175 | $0 | 13,850 (Direct) |
View |
2022-02-01 Option Award |
2022-02-09 8:59 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Franchini Indrani Lall EVP, CLO & Secretary |
44,707 | $0 | 44,707 (Direct) |
View |
2021-07-14 Option Award |
2021-07-16 4:53 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
52,625 | $0 | 116,075 (Direct) |
View |
2021-06-08 Tax Withholding |
2021-06-09 4:50 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
928 | $177 | 63,450 (Direct) |
View |
2021-02-28 Option Award |
2021-03-02 5:54 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
18,033 | $0 | 64,378 (Direct) |
View |
2020-12-16 Option Award |
2020-12-18 5:08 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
37,965 | $0 | 46,345 (Direct) |
View |
2020-12-16 Tax Withholding |
2020-12-18 5:08 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
19,838 | $157.96 | 46,345 (Direct) |
View |
2020-06-08 Tax Withholding |
2020-06-09 5:05 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer |
1,403 | $114.61 | 28,218 (Direct) |
View |